MetaCap

Iambic Therapeutics Inc. Company Profile

NASDAQ: IAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

13.11-1.15 (-8.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Iambic Therapeutics at a glance

Iambic Therapeutics Inc. (NASDAQ: IAM) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in San Diego, CA. Iambic Therapeutics is led by Dr. Thomas Miller Ph.D. and employs about 171 people. The company's shares have traded publicly since 2026.

At a market capitalization of $621.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001997038, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Iambic Therapeutics do?

Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally. It offers products, such as IAM-1363, a selective HER2 inhibitor; IAM-K1, a KIF18A inhibitor; IAM217 (a KIF18A inhibitor) and IAM-C1, a CDK2/4 inhibitor; and services, including drug discovery platform and molecular superintelligence platform which includes technologies, such as Enchant and NeuralPLexer to design and develop small molecule therapeutics. Iambic Therapeutics, Inc. was formerly known as Entos, Inc. and changed its name to Iambic Therapeutics, Inc. in May 2023. The company was incorporated in 2019 and is based in San Diego, California.

Business description based on the company's public filings.

Company information

Legal name
Iambic Therapeutics Inc.
Ticker
NASDAQ: IAM
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Dr. Thomas Miller Ph.D.
Employees
171
Headquarters
5627 Oberlin Drive, San Diego, CA, United States
Phone
(619) 330-5499
Website
iambic.ai
IPO year
2026
Market cap
$621.42M
SEC CIK
0001997038

Companies similar to Iambic Therapeutics

IAM peer companies
CompanyPrice% ChgMarket capCompare
SRZNSurrozen Inc.28.46-7.21%$596.40Mvs IAM
CGEMCullinan Therapeutics Inc.8.89-1.98%$577.15Mvs IAM
FDMT4D Molecular Therapeutics Inc.10.23-4.57%$576.76Mvs IAM
ENTXEntera Bio Ltd.3.31+0.76%$575.53Mvs IAM
DBVTDBV Technologies S.A. ADR9.02-4.25%$566.82Mvs IAM
ATTOAttovia Therapeutics Inc.15.10-3.08%$690.26Mvs IAM
SLDBSolid Biosciences Inc.6.25-2.95%$697.57Mvs IAM
AURAAura Biosciences Inc.6.87-1.58%$714.99Mvs IAM

Related